Financhill
Sell
27

NMTC Quote, Financials, Valuation and Earnings

Last price:
$0.61
Seasonality move :
3.37%
Day range:
$0.61 - $0.65
52-week range:
$0.40 - $1.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.16x
P/B ratio:
27.04x
Volume:
88.1K
Avg. volume:
302.2K
1-year change:
-35.34%
Market cap:
$30.4M
Revenue:
$3.5M
EPS (TTM):
-$0.22

Earnings Data

Next earnings date for NMTC
Aug 14
2025
Most recent earnings per share
-$0.07
Missed by $0.07
(May 13/2025)
Consensus Estimate
--
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NMTC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $1.8M -- -- -- --
05/13/2025 Q1 $1.3M $1.4M -$0.07 -- --
02/12/2025 Q4 -- $3.3M $0.06 -- --
12/17/2024 Q3 -- $272.3K -$0.11 -- --
08/14/2024 Q2 -- $825.8K -$0.10 -- --
05/14/2024 Q1 -- $1.4M -$0.11 -- --
02/13/2024 Q4 $852K $977.7K -$0.14 -$0.14 --
12/14/2023 Q3 -- -- -$0.13 -$0.18 $0.05
08/11/2023 Q2 -- -- -$0.20 -$0.21 $0.00
05/12/2023 Q1 -- -- -$0.21 -$0.21 -$0.01
02/14/2023 Q4 -- -- -$0.11 -$0.11 --
12/13/2022 Q3 -- -- -$0.09 -$0.11 $0.02
08/11/2022 Q2 -- -- -$0.17 -$0.23 $0.06
05/12/2022 Q1 -- -- -$0.19 -$0.20 $0.01
02/14/2022 Q4 -- -- -$0.18 -$0.19 $0.01
12/15/2021 Q3 -- -- -$0.22 -$0.24 $0.02
08/13/2021 Q2 -- -- -$0.25 -- --
05/14/2021 Q1 -- -- -$0.21 -- --
12/31/2020 Q4 -- -- -$0.27 -- --
09/30/2020 Q3 -- -- $0.18 -- --
06/30/2020 Q2 -- -- -$1.32 -- --
03/31/2020 Q1 -- -- -$0.87 -- --
12/31/2019 Q4 -- -- -$1.02 -- --
09/30/2019 Q3 -- -- -$0.27 -- --
06/30/2019 Q2 -- -- -$0.42 -- --
03/31/2019 Q1 -- -- -$0.60 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.48 -- --
03/31/2018 Q1 -- -- -$0.51 -- --
12/31/2017 Q4 -- -- -$0.66 -- --
09/30/2017 Q3 -- -- -$0.57 -- --
06/30/2017 Q2 -- -- -$0.66 -- --
03/31/2017 Q1 -- -- -$0.42 -- --
12/31/2016 Q4 -- -- -$0.18 -- --
09/30/2016 Q3 -- -- -$0.00 -- --
06/30/2016 Q2 -- -- -$0.01 -- --
03/31/2016 Q1 -- -- -$0.01 -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -$0.01 -- --
06/30/2015 Q2 -- -- -$0.01 -- --

NeuroOne Medical Technologies Earnings Questions

  • How Much did NeuroOne Medical Technologies Generate in Revenue Last Quarter?

    NeuroOne Medical Technologies reported $1.4M worth of top line sales in its most recent quarter.

  • Did NeuroOne Medical Technologies Beat Earnings Last Quarter?

    NeuroOne Medical Technologies announced earnings per share of -$0.07 which represents a miss of analyst forecast a -- per share.

  • Is NeuroOne Medical Technologies Profitable?

    NeuroOne Medical Technologies reported $771.1K that represents $0.02 per share over the last quarter.

  • What is the Analyst Consensus for NeuroOne Medical Technologies EPS Next Year?

    NeuroOne Medical Technologies's earnings are forecast to decrease from -$0.46 per share to -$0.70 per share next year representing a decrease of -36.92%.

  • When is NeuroOne Medical Technologies's Earnings Date?

    NeuroOne Medical Technologies's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock